You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR ADVIL MIGRAINE LIQUI-GELS


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for ADVIL MIGRAINE LIQUI-GELS

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT01687101 ↗ STOPAIN in the Treatment of a Single Migraine Attack Completed Thomas Jefferson University N/A 2012-05-01 This is an open label pilot study of 25 subjects with a diagnosis of episodic migraine with or without aura. STOPAIN is an over-the-counter product that is used for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains. We plan to have subjects apply the product during a single migraine attack to see if it will alleviate the headache pain and associated symptoms.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for ADVIL MIGRAINE LIQUI-GELS

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004654 ↗ Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia Completed Yale University Phase 3 1996-01-01 OBJECTIVES: I. Evaluate migraine prophylaxis with soy protein isolate in patients with hereditary hemorrhagic telangiectasia. II. Assess whether soy protein isolate reduces the frequency and severity of epistaxis and gastrointestinal bleeding in these patients.
NCT00004654 ↗ Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia Completed National Center for Research Resources (NCRR) Phase 3 1996-01-01 OBJECTIVES: I. Evaluate migraine prophylaxis with soy protein isolate in patients with hereditary hemorrhagic telangiectasia. II. Assess whether soy protein isolate reduces the frequency and severity of epistaxis and gastrointestinal bleeding in these patients.
NCT00055484 ↗ A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache Completed Elan Pharmaceuticals Phase 2 2002-03-01 The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ADVIL MIGRAINE LIQUI-GELS

Condition Name

Condition Name for ADVIL MIGRAINE LIQUI-GELS
Intervention Trials
Migraine 323
Migraine Disorders 84
Migraine Headache 46
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ADVIL MIGRAINE LIQUI-GELS
Intervention Trials
Migraine Disorders 641
Headache 225
Migraine without Aura 52
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ADVIL MIGRAINE LIQUI-GELS

Trials by Country

Trials by Country for ADVIL MIGRAINE LIQUI-GELS
Location Trials
Denmark 99
United Kingdom 97
Poland 93
Germany 90
Italy 70
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ADVIL MIGRAINE LIQUI-GELS
Location Trials
California 173
New York 169
Florida 160
Missouri 150
Texas 140
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ADVIL MIGRAINE LIQUI-GELS

Clinical Trial Phase

Clinical Trial Phase for ADVIL MIGRAINE LIQUI-GELS
Clinical Trial Phase Trials
Phase 4 184
Phase 3 233
Phase 2/Phase 3 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ADVIL MIGRAINE LIQUI-GELS
Clinical Trial Phase Trials
Completed 465
Recruiting 125
Not yet recruiting 82
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADVIL MIGRAINE LIQUI-GELS

Sponsor Name

Sponsor Name for ADVIL MIGRAINE LIQUI-GELS
Sponsor Trials
Danish Headache Center 52
GlaxoSmithKline 39
Merck Sharp & Dohme Corp. 37
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ADVIL MIGRAINE LIQUI-GELS
Sponsor Trials
Other 614
Industry 523
U.S. Fed 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.